Correlation Between GlaxoSmithKline PLC and SuperVerse

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and SuperVerse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and SuperVerse into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and SuperVerse, you can compare the effects of market volatilities on GlaxoSmithKline PLC and SuperVerse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of SuperVerse. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and SuperVerse.

Diversification Opportunities for GlaxoSmithKline PLC and SuperVerse

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and SuperVerse is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and SuperVerse in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SuperVerse and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with SuperVerse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SuperVerse has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and SuperVerse go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and SuperVerse

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 2247.93 times less return on investment than SuperVerse. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 42.39 times less risky than SuperVerse. It trades about 0.0 of its potential returns per unit of risk. SuperVerse is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  9.79  in SuperVerse on August 27, 2024 and sell it today you would earn a total of  121.21  from holding SuperVerse or generate 1238.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy60.28%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  SuperVerse

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
SuperVerse 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SuperVerse are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, SuperVerse exhibited solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and SuperVerse Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and SuperVerse

The main advantage of trading using opposite GlaxoSmithKline PLC and SuperVerse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, SuperVerse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SuperVerse will offset losses from the drop in SuperVerse's long position.
The idea behind GlaxoSmithKline PLC ADR and SuperVerse pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account